Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU

21 Mar 2015

Abstract excerpt

// Xin Li 1, 4 , Jie Yu 1 , Malcolm V. Brock 2 , Qian Tao 3 , James G. Herman 2 , Ping Liang 1 , Mingzhou Guo 4 1 Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China 2 Oncology Center, Johns Hopkins University, Baltimore, Maryland, USA 3 Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China 4 Department of Gastroenterology & Hepatology, Chinese...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Cancer-related Molecular Pathways
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25909168
DOI: 10.18632/oncotarget.3413

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FUPMID 25909168Read ↗

A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylationSemantic proximity Read ↗

Epigenetic inactivation of BCL6B , a novel functional tumour suppressor for gastric cancer, is associated with poor survivalSemantic proximity Read ↗

Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 proteinSemantic proximity Read ↗

BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosisSemantic proximity Read ↗

BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activitySemantic proximity Read ↗

BIRC6 promotes hepatocellular carcinogenesis: Interaction of BIRC 6 with p53 facilitating p53 degradationSemantic proximity Read ↗

Decreased expression of miR‑3135b reduces sensitivity to 5‑fluorouracil in colorectal cancer by direct repression of PIM1Semantic proximity Read ↗

B cell lymphoma 6 promotes hepatocellular carcinoma progression by inhibition tumor infiltrating CD4+T cell cytotoxicity through ESM1Semantic proximity Read ↗

KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.Semantic proximity Read ↗

DNMT1 inhibits hepatocellular carcinoma cells by altering the epigenetic modification of Marveld1 geneSemantic proximity Read ↗

DNMT1 inhibits hepatocellular carcinoma cells by altering the epigenetic modification of Marveld1 geneSemantic proximity Read ↗

Effect of let‑7c on the PI3K/Akt/FoxO signaling pathway in hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.